Cargando…
COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis
Autores principales: | Farfour, E., Ballester, M-C., Lecuru, M., Verrat, A., Imhaus, E., Mellot, F., Karnycheff, F., Vasse, M., Cerf, C., Lesprit, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194691/ https://www.ncbi.nlm.nih.gov/pubmed/32343984 http://dx.doi.org/10.1016/j.jhin.2020.04.021 |
Ejemplares similares
-
Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19
por: Farfour, Eric, et al.
Publicado: (2020) -
SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis
por: Farfour, Eric, et al.
Publicado: (2020) -
COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful
por: Farfour, Eric, et al.
Publicado: (2020) -
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?
por: Farfour, Eric, et al.
Publicado: (2020) -
Prognostic value of cellular population data in patients with COVID-19
por: Vasse, Marc, et al.
Publicado: (2023)